ArticleFrontiers in oncology2025

Oxaliplatin versus irinotecan as first-line therapy in metastatic colorectal cancer with prior adjuvant treatment: a retrospective study on efficacy, sequential therapy, and the impact of thrombocytopenia.

Han Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.